What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic?

Science Translational Medicine  14 Nov 2012:
Vol. 4, Issue 160, pp. 160cm14
DOI: 10.1126/scitranslmed.3004915

You are currently viewing the abstract.

View Full Text


Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.

View Full Text